ACUTE MYELOGENOUS LEUKEMIA
Clinical trials for ACUTE MYELOGENOUS LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOGENOUS LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE MYELOGENOUS LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New transplant method opens door for more blood cancer patients
Disease control OngoingThis trial is testing a stem cell transplant method for people with blood cancers who don't have a perfectly matched donor. It uses stem cells from a partially matched, unrelated donor along with specific medications to prevent complications. The main goal is to see if this appro…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New pill tested for Tough-to-Treat leukemias
Disease control TerminatedThis study is testing a new oral drug called CA-4948 (emavusertib) for adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) that has come back or hasn't responded to prior treatments. The main goals are to find the safest and most effective dose an…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Curis, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Vaccine trial aims to train immune system to fight off leukemia
Disease control OngoingThis study is testing a cancer vaccine for people with a type of blood cancer called AML who have just finished chemotherapy and are in remission. The goal is to see if the vaccine can help the body's own immune system recognize and attack any remaining cancer cells, which could …
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Personalized vaccine trial aims to train immune system to fight leukemia
Disease control OngoingThis early-stage study is testing the safety of a personalized cancer vaccine for people with acute myeloid leukemia (AML) who have recently had a stem cell transplant. The vaccine is made by fusing a patient's own immune cells with their leukemia cells, aiming to teach the body'…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE1 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Scientists collect cancer samples to hunt for future cures
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood and bone marrow samples from people with blood cancers like leukemia and lymphoma. Researchers will study these samples in the lab to better understand how these cancers work. The goal is to find new targets for future treatments and improve detection me…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC